期刊
EXPERT REVIEW OF VACCINES
卷 14, 期 10, 页码 1331-1346出版社
TAYLOR & FRANCIS LTD
DOI: 10.1586/14760584.2015.1078732
关键词
effectiveness; efficacy; influenza vaccine; live attenuated influenza vaccine; school-age children
类别
资金
- MedImmune
- AstraZeneca
Evidence of high efficacy of live attenuated influenza vaccine (LAIV) from randomized controlled trials is strong for children 2-6 years of age, but fewer data exist for older school-age children. We reviewed the published data on efficacy and effectiveness of LAIV in children >= 5 years. QUOSA (Elsevier database) was searched for articles published from January 1990 to June 2014 that included 'FluMist', 'LAIV', 'CAIV', 'cold adapted influenza vaccine', 'live attenuated influenza vaccine', 'live attenuated cold adapted' or 'flu mist'. Studies evaluated included randomized controlled trials, effectiveness and indirect protection studies. This review demonstrates that LAIV has considerable efficacy and effectiveness in school-age children.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据